These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 14995055)
1. New support for branched-chain amino acid supplementation in advanced hepatic failure. Mascarenhas R; Mobarhan S Nutr Rev; 2004 Jan; 62(1):33-8. PubMed ID: 14995055 [TBL] [Abstract][Full Text] [Related]
2. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220 [TBL] [Abstract][Full Text] [Related]
3. Branched-chain amino acid enriched supplements as therapy for liver disease. Charlton M J Nutr; 2006 Jan; 136(1 Suppl):295S-8S. PubMed ID: 16365102 [TBL] [Abstract][Full Text] [Related]
4. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Holecek M Nutrition; 2010 May; 26(5):482-90. PubMed ID: 20071143 [TBL] [Abstract][Full Text] [Related]
5. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis. Kawaguchi T; Taniguchi E; Sata M Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292 [TBL] [Abstract][Full Text] [Related]
6. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Yoshida T; Muto Y; Moriwaki H; Yamato M Gastroenterol Jpn; 1989 Dec; 24(6):692-8. PubMed ID: 2606303 [TBL] [Abstract][Full Text] [Related]
7. Branched-chain amino acids for people with hepatic encephalopathy. Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177 [TBL] [Abstract][Full Text] [Related]
9. Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation. Holeček M Nutrition; 2017 Sep; 41():80-85. PubMed ID: 28760433 [TBL] [Abstract][Full Text] [Related]
10. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H; Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505 [TBL] [Abstract][Full Text] [Related]
11. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis. Ruiz-Margáin A; Macías-Rodríguez RU; Ríos-Torres SL; Román-Calleja BM; Méndez-Guerrero O; Rodríguez-Córdova P; Torre A Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):9-15. PubMed ID: 28408059 [TBL] [Abstract][Full Text] [Related]
13. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy. Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073 [TBL] [Abstract][Full Text] [Related]
14. Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications. Holecek M Nutrition; 2013 Oct; 29(10):1186-91. PubMed ID: 23756281 [TBL] [Abstract][Full Text] [Related]
15. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study. Park JG; Tak WY; Park SY; Kweon YO; Chung WJ; Jang BK; Bae SH; Lee HJ; Jang JY; Suk KT; Oh MJ; Heo J; Woo HY; Jang SY; Lee YR; Lee JS; Kim DY; Kim SH; Suh JI; Kim IH; Kang MK; Lee WK Nutrients; 2020 May; 12(5):. PubMed ID: 32429077 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis. Konstantis G; Pourzitaki C; Chourdakis M; Kitsikidou E; Germanidis G Clin Nutr; 2022 Jun; 41(6):1171-1190. PubMed ID: 35500317 [TBL] [Abstract][Full Text] [Related]
17. Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review. Metcalfe EL; Avenell A; Fraser A Clin Nutr; 2014 Dec; 33(6):958-65. PubMed ID: 24656171 [TBL] [Abstract][Full Text] [Related]
18. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. Marchesini G; Dioguardi FS; Bianchi GP; Zoli M; Bellati G; Roffi L; Martines D; Abbiati R J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661 [TBL] [Abstract][Full Text] [Related]
19. Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy. Mumtaz S; Ford AC Am J Gastroenterol; 2011 Sep; 106(9):1718; author reply 1718-9. PubMed ID: 21897411 [No Abstract] [Full Text] [Related]
20. The usefulness of branched chain amino acids in patients with acute or chronic hepatic encephalopathy. Alexander WF; Spindel E; Harty RF; Cerda JJ Am J Gastroenterol; 1989 Feb; 84(2):91-6. PubMed ID: 2644820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]